These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2913725)

  • 21. Drug-induced cardiotoxicity studied by longitudinal B-type natriuretic peptide assays and radionuclide ventriculography.
    Pichon MF; Cvitkovic F; Hacene K; Delaunay J; Lokiec F; Collignon MA; Pecking AP
    In Vivo; 2005; 19(3):567-76. PubMed ID: 15875778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Long-term study of anthracycline-induced cardiomyopathy in children and adolescents].
    Koch H; Schmitz L; Brockmeier K; Hartmann R; Bein G; Henze G
    Klin Padiatr; 1991; 203(4):262-7. PubMed ID: 1942932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [On the problem of the cardiotoxicity of epirubicin-cisplatin].
    Lechner W; Zechmann W; Mayr P; Reider W; Marth C
    Zentralbl Gynakol; 1988; 110(7):429-32. PubMed ID: 3164959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A longitudinal study of cardiac function in children with cancer over 40 months.
    Li CK; Sung RY; Kwok KL; Leung TF; Shing MM; Chik KW; Yu CW; Yam MC; Yuen PM
    Pediatr Hematol Oncol; 2000; 17(1):77-83. PubMed ID: 10689717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Is the use of adriamycin (doxorubicin) limited by its cardiotoxicity?].
    Reinhardt D; Hofmann V; Martz G
    Schweiz Med Wochenschr; 1985 Apr; 115(16):557-61. PubMed ID: 4001904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pediatric heart transplantation for anthracycline cardiomyopathy: cancer recurrence is rare.
    Ward KM; Binns H; Chin C; Webber SA; Canter CE; Pahl E
    J Heart Lung Transplant; 2004 Sep; 23(9):1040-5. PubMed ID: 15454169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Myocardiopathy from a new anthracyclic derivative (author's transl)].
    Montely JM; Gay J; Benoit P; Fontaliran F; Gerbaux A
    Ann Med Interne (Paris); 1979 Dec; 130(12):709-14. PubMed ID: 539690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late cardiac evaluation of children with solid tumors after anthracycline chemotherapy.
    Pinarli FG; Oğuz A; Tunaoğlu FS; Karadeniz C; Gökçora N; Elbeg S
    Pediatr Blood Cancer; 2005 Apr; 44(4):370-7. PubMed ID: 15602715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of left ventricular function in patients with mammary carcinoma after treatment with epidoxorubicin using a high-dose, short-term protocol].
    D'Alto M; Maurea S; Basso A; Polverino W; Bianchi U; Bonelli A; Silvestro P; Salvatore M; Chiariello M
    Cardiologia; 1997 Jun; 42(6):611-8. PubMed ID: 9289377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I-II trial of high-dose epirubicin in patients with lymphoma.
    Case DC; Gams R; Ervin TJ; Boyd MA; Oldham FB
    Cancer Res; 1987 Dec; 47(23):6393-6. PubMed ID: 3479245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer.
    Klein JL; Rey PM; Dansey RD; Karanes C; Du W; Abella E; Cassells L; Hamm C; Peters WP; Baynes RD
    Bone Marrow Transplant; 2000 May; 25(10):1047-52. PubMed ID: 10828864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy.
    Torti FM; Bristow MM; Lum BL; Carter SK; Howes AE; Aston DA; Brown BW; Hannigan JF; Meyers FJ; Mitchell EP
    Cancer Res; 1986 Jul; 46(7):3722-7. PubMed ID: 3458531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early detection of anthracycline-induced cardiotoxicity by radionuclide angiocardiography.
    Suzuki J; Yanagisawa A; Shigeyama T; Tsubota J; Yasumura T; Shimoyama K; Ishikawa K
    Angiology; 1999 Jan; 50(1):37-45. PubMed ID: 9924887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radionuclide ejection fraction in doxorubicin cardiotoxicity.
    Morgan GW; McIlveen BM; Freedman A; Murray IP
    Cancer Treat Rep; 1981; 65(7-8):629-38. PubMed ID: 7248982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Daunomycin-and adriamycin-induced cardiomyopathy--relationship between dosage of drugs and histopathological findings (author's transl)].
    Yamaguchi H; Toyota S; Takahara O; Ichimaru M
    Rinsho Ketsueki; 1978 Aug; 19(8):1041-50. PubMed ID: 713049
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diagnosis of adriamycin myocardiopathy using echocardiography].
    Harpf H; Lehnert M; Tschech G
    Acta Med Austriaca Suppl; 1979; 6():341-3. PubMed ID: 299226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anthracycline induced myocardial damage. An analysis of 16 autopsy cases.
    Kajihara H; Yokozaki H; Yamahara M; Kadomoto Y; Tahara E
    Pathol Res Pract; 1986 Aug; 181(4):434-41. PubMed ID: 3463940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial function and postmortem myocardial histology in children given anthracycline therapy for cancer.
    Pihkala J; Sariola H; Saarinen UM
    Pediatr Hematol Oncol; 1994; 11(3):259-69. PubMed ID: 8060810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiotoxicity of anthracycline cytostatic agents--a proposal for routine monitoring and supportive therapy].
    Svojgrová M; Slechtová J; Hůla J
    Vnitr Lek; 1991 Feb; 37(2):151-9. PubMed ID: 2021075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac toxicity of adriamycin-DNA complex and rubidazone: evaluation by electrocardiogram and endomyocardial biopsy.
    Benjamin RS; Mason JW; Billingham ME
    Cancer Treat Rep; 1978 Jun; 62(6):935-9. PubMed ID: 667871
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.